Observational Non-Interventional Study Of Febrile Neutropenia Patients To

See also
Status	Clinical Trial	Phase
Completed	`NCT03641131` - Ampholipad Real-World Data in Taiwan
Not yet recruiting	`NCT02806557` - Profiling Neutrophil Counts in Patients on Chemotherapy	N/A
Completed	`NCT04914702` - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Completed	`NCT02728596` - S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	N/A
Completed	`NCT03104595` - Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer	Phase 1/Phase 2
Recruiting	`NCT02536599` - Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
Completed	`NCT02005783` - Study of Danggui Buxue Decoction in Preventing Neutropenia	Phase 2
Recruiting	`NCT03449693` - Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia	Phase 2
Recruiting	`NCT05149547` - mNGS Versus Blood Culture in FN
Recruiting	`NCT05584930` - Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN)	N/A
Completed	`NCT04134429` - Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy
Recruiting	`NCT01684189` - Registry of Febrile Neutropenia and Invasive Fungal Infections	N/A
Completed	`NCT00462878` - Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation	N/A
Completed	`NCT00035425` - Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection	Phase 3
Recruiting	`NCT04948463` - Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia	Phase 4
Recruiting	`NCT03740464` - Long-acting G-CSF for Febrile Neutropenia	Phase 3
Not yet recruiting	`NCT06116734` - Lapelga vs Gastrofil	Phase 3
Completed	`NCT00503854` - Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
Terminated	`NCT02732327` - Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer	Phase 2
Completed	`NCT01114165` - Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients	Phase 4

NCT number	NCT00945555
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase	Phase 4
Start date	June 2009
Completion date	October 2010

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms